1. Structural Biology and Molecular Biophysics
  2. Neuroscience

Cooperative and acute inhibitionby multiple C-terminal motifs of L-type Ca2+ channels

  1. Nan Liu
  2. Yaxiong Yang
  3. Lin Ge
  4. Min Liu
  5. Henry M Colecraft
  6. Xiaodong Liu  Is a corresponding author
  1. Tsinghua University, China
  2. Columbia University, United States
https://doi.org/10.7554/eLife.21989
Share this article
Cite this article
  1. Nan Liu
  2. Yaxiong Yang
  3. Lin Ge
  4. Min Liu
  5. Henry M Colecraft
  6. Xiaodong Liu
(2017)
Cooperative and acute inhibitionby multiple C-terminal motifs of L-type Ca2+ channels
eLife 6:e21989.
https://doi.org/10.7554/eLife.21989
  2. Download BibTeX
  3. Download .RIS

Abstract

Inhibitions and antagonists of L-type Ca2+ channels are important to both research and therapeutics. Here, we report C-terminus mediated inhibition (CMI) for CaV1.3 that multiple motifs coordinate to tune down Ca2+ current and Ca2+ influx toward the lower limits determined by end-stage CDI (Ca2+-dependent inactivation). Among IQV (preIQ3-IQ domain), PCRD and DCRD (proximal or distal C-terminal regulatory domain), spatial closeness of any two modules, e.g., by constitutive fusion, facilitates the trio to form the complex, compete against calmodulin, and alter the gating. Acute CMI by rapamycin-inducible heterodimerization helps reconcile the concurrent activation/inactivation attenuations to ensure Ca2+ influx is reduced, in that Ca2+ current activated by depolarization is potently (~65%) inhibited at the peak (full activation), but not later on (end-stage inactivation, ~300 ms). Meanwhile, CMI provides a new paradigm to develop CaV1 inhibitors, the therapeutic potential of which is implied by computational modeling of CaV1.3 dysregulations related to Parkinson's disease.

Article and author information

Author details

  1. Nan Liu

    X-Lab for Transmembrane Signaling Research, Department of Biomedical Engineering, Tsinghua University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9606-4732

  2. Yaxiong Yang

    X-Lab for Transmembrane Signaling Research, Department of Biomedical Engineering, Tsinghua University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  3. Lin Ge

    X-Lab for Transmembrane Signaling Research, Department of Biomedical Engineering, Tsinghua University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  4. Min Liu

    X-Lab for Transmembrane Signaling Research, Department of Biomedical Engineering, Tsinghua University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  5. Henry M Colecraft

    Department of Physiology and Cellular Biophysics, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.

  6. Xiaodong Liu

    X-Lab for Transmembrane Signaling Research, Department of Biomedical Engineering, Tsinghua University, Beijing, China
    For correspondence
    liuxiaodong@tsinghua.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3171-9611

Funding

National Natural Science Foundation of China (81171382,31370822,81371604)

  • Xiaodong Liu

Natural Science Foundation of Beijing Municipality (7142089)

  • Xiaodong Liu

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Liu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,141
    views
  • 391
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nan Liu
  2. Yaxiong Yang
  3. Lin Ge
  4. Min Liu
  5. Henry M Colecraft
  6. Xiaodong Liu
(2017)
Cooperative and acute inhibitionby multiple C-terminal motifs of L-type Ca2+ channels
eLife 6:e21989.
https://doi.org/10.7554/eLife.21989

Share this article

https://doi.org/10.7554/eLife.21989

Categories and tags

Further reading

    1. Structural Biology and Molecular Biophysics

    Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγ

    Jinsai Shang, Douglas J Kojetin
    Research Advance

    Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics

    Isobaric crosslinking mass spectrometry technology for studying conformational and structural changes in proteins and complexes

    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.

    1. Structural Biology and Molecular Biophysics

    Structure of scavenger receptor SCARF1 and its interaction with lipoproteins

    Yuanyuan Wang, Fan Xu ... Yongning He
    Research Article

    SCARF1 (scavenger receptor class F member 1, SREC-1 or SR-F1) is a type I transmembrane protein that recognizes multiple endogenous and exogenous ligands such as modified low-density lipoproteins (LDLs) and is important for maintaining homeostasis and immunity. But the structural information and the mechanisms of ligand recognition of SCARF1 are largely unavailable. Here, we solve the crystal structures of the N-terminal fragments of human SCARF1, which show that SCARF1 forms homodimers and its epidermal growth factor (EGF)-like domains adopt a long-curved conformation. Then, we examine the interactions of SCARF1 with lipoproteins and are able to identify a region on SCARF1 for recognizing modified LDLs. The mutagenesis data show that the positively charged residues in the region are crucial for the interaction of SCARF1 with modified LDLs, which is confirmed by making chimeric molecules of SCARF1 and SCARF2. In addition, teichoic acids, a cell wall polymer expressed on the surface of gram-positive bacteria, are able to inhibit the interactions of modified LDLs with SCARF1, suggesting the ligand binding sites of SCARF1 might be shared for some of its scavenging targets. Overall, these results provide mechanistic insights into SCARF1 and its interactions with the ligands, which are important for understanding its physiological roles in homeostasis and the related diseases.